8-K 1 form8k.txt FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 24, 2003 CELGENE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-16132 22-2711928 -------------------------------------------------------------------------------- (State or other jurisdiction of (Commission File Number) (IRS Employer incorporation) Identification No.) 7 Powder Horn Drive, Warren, New Jersey 07059 -------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (732) 271-1001 -------------------------------------------------------------------------------- (Former name or former address, if changed since last report.) ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS. (c) Exhibit 99.1 - Press Release dated July 24, 2003. ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On July 24, 2003, Celgene Corporation announced its earnings for the quarter ended June 30, 2003. Attached hereto and incorporated herein by reference as Exhibit 99.1 is the Press Release announcing such results. SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CELGENE CORPORATION Date: August 4, 2003 By: /s/ Robert J. Hugin --------------------------------- Name: Robert J. Hugin Title: Senior Vice President and Chief Financial Officer